
ALT Two graphs from an Original Article published in the New England Journal of Medicine article titled “Ianalumab for the Treatment of Patients with Sjögren’s Disease.” The graphs show the change in ESSDAI score over time (full analysis population) for both trials, NEPTUNUS-1 and NEPTUNUS-2. The NEJM identity sits at the bottom.

ALT "What abled people dont understand is that even if a disabled person manages to do A Thing, there is a cost for A Thing We had a family member hours today visit for 3 hours. I collapsed from pain and fatigue when they left and slept for 10 hours straight. If you don't have to factor in losing 40% of your day in exchange for A Thing, you have no right to comment on my ability to do A Thing. Credit: Women With Chronic lllness #PainAwarenessMonth #PAM2026 #MySeveralWorlds #ArthritisAwarenessMonth #MigraineAwarenessWeek


























